SS
UTHR icon

Sunbelt Securities’s United Therapeutics UTHR Stock Holding History

Sunbelt Securities’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.6K Sell
23
-4
-15% -$1.99K ﹤0.01% 1413
2025
Q4 		$13.2K Buy
27
+7
+35% +$3.26K ﹤0.01% 1370
2025
Q3 		$8.38K Hold
20
– – ﹤0.01% 1481
2025
Q2 		$7.06K Hold
20
– – ﹤0.01% 1377
2025
Q1 		$6.17K Hold
20
– – ﹤0.01% 1373
2024
Q4 		$7.15K Hold
20
– – ﹤0.01% 1379
2024
Q3 		$7.17K Hold
20
– – ﹤0.01% 1363
2024
Q2 		$6.37K Hold
20
– – ﹤0.01% 1350
2024
Q1 		$4.59K Hold
20
– – ﹤0.01% 1383
2023
Q4 		$4.4K Hold
20
– – ﹤0.01% 1331
2023
Q3 		$4.52K Hold
20
– – ﹤0.01% 1336
2023
Q2 		$4.42K Hold
20
– – ﹤0.01% 1347
2023
Q1 		$4.38K Buy
+20
New +$4.93K ﹤0.01% 1321

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Sunbelt Securities's UTHR Position: Q1 2026 in Review

Sunbelt Securities reduced its United Therapeutics (UTHR) stake by 15% in Q1 2026, selling an estimated $1.99K and leaving 23 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

Sunbelt Securities first reported a position in UTHR in Q1 2023 and has held it in 13 quarters since. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Sunbelt Securities held 23 shares of United Therapeutics worth $13.6K as of Q1 2026.
  • Sunbelt Securities sold 4 United Therapeutics shares in Q1 2026, an estimated $1.99K.
  • United Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1413 holding.
  • Sunbelt Securities first reported a position in United Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.